231 related articles for article (PubMed ID: 32087357)
1. The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up.
Mittal S; Wilkoff BL; Kennergren C; Poole JE; Corey R; Bracke FA; Curnis A; Addo K; Martinez-Arraras J; Issa ZF; Redpath C; Moubarak J; Khelae SK; Boersma LVA; Korantzopoulos P; Krueger J; Lande JD; Morss GM; Seshadri S; Tarakji KG
Heart Rhythm; 2020 Jul; 17(7):1115-1122. PubMed ID: 32087357
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
Tarakji KG; Mittal S; Kennergren C; Corey R; Poole JE; Schloss E; Gallastegui J; Pickett RA; Evonich R; Philippon F; McComb JM; Roark SF; Sorrentino D; Sholevar D; Cronin E; Berman B; Riggio D; Biffi M; Khan H; Silver MT; Collier J; Eldadah Z; Wright DJ; Lande JD; Lexcen DR; Cheng A; Wilkoff BL;
N Engl J Med; 2019 May; 380(20):1895-1905. PubMed ID: 30883056
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
[TBL] [Abstract][Full Text] [Related]
4. Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis.
Tarakji KG; Korantzopoulos P; Philippon F; Biffi M; Mittal S; Poole JE; Kennergren C; Lexcen DR; Lande JD; Seshadri S; Wilkoff BL
Heart Rhythm; 2021 Dec; 18(12):2080-2086. PubMed ID: 34280568
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial.
Wilkoff BL; Boriani G; Mittal S; Poole JE; Kennergren C; Corey GR; Krahn AD; Schloss EJ; Gallastegui JL; Pickett RA; Evonich RF; Roark SF; Sorrentino DM; Sholevar DP; Cronin EM; Berman BJ; Riggio DW; Khan HH; Silver MT; Collier J; Eldadah Z; Holbrook R; Lande JD; Lexcen DR; Seshadri S; Tarakji KG
Circ Arrhythm Electrophysiol; 2020 Oct; 13(10):e008503. PubMed ID: 32915063
[TBL] [Abstract][Full Text] [Related]
6. Clinical Presentation, Timing, and Microbiology of CIED Infections: An Analysis of the WRAP-IT Trial.
Sohail MR; Corey GR; Wilkoff BL; Poole JE; Mittal S; Kennergren C; Greenspon AJ; Cheng A; Lande JD; Lexcen DR; Tarakji KG
JACC Clin Electrophysiol; 2021 Jan; 7(1):50-61. PubMed ID: 33478712
[TBL] [Abstract][Full Text] [Related]
7. Worldwide Randomized Antibiotic EnveloPe Infection PrevenTion Trial (WRAP-IT).
Tarakji KG; Mittal S; Kennergren C; Corey R; Poole J; Stromberg K; Lexcen DR; Wilkoff BL
Am Heart J; 2016 Oct; 180():12-21. PubMed ID: 27659878
[TBL] [Abstract][Full Text] [Related]
8. Impact of Cardiac Implantable Electronic Device Infection: A Clinical and Economic Analysis of the WRAP-IT Trial.
Wilkoff BL; Boriani G; Mittal S; Poole JE; Kennergren C; Corey GR; Love JC; Augostini R; Faerestrand S; Wiggins SS; Healey JS; Holbrook R; Lande JD; Lexcen DR; Willey S; Tarakji KG;
Circ Arrhythm Electrophysiol; 2020 May; 13(5):e008280. PubMed ID: 32281393
[TBL] [Abstract][Full Text] [Related]
9. Randomized Trial of Stand-Alone Use of the Antimicrobial Envelope in High-Risk Cardiac Device Patients.
Ellis CR; Greenspon AJ; Andriulli JA; Gould PA; Carillo RG; Kolek MJ; Donegan R; Amaral AP; Mittal S
Circ Arrhythm Electrophysiol; 2023 May; 16(5):e011740. PubMed ID: 36960716
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the antibacterial envelope to prevent cardiac implantable electronic device infection in a high-risk population.
Chaudhry U; Borgquist R; Smith JG; Mörtsell D
Europace; 2022 Dec; 24(12):1973-1980. PubMed ID: 35989511
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for CIED Infection After Secondary Procedures: Insights From the WRAP-IT Trial.
Tarakji KG; Krahn AD; Poole JE; Mittal S; Kennergren C; Biffi M; Korantzopoulos P; Dallaglio PD; Lexcen DR; Lande JD; Hilleren G; Holbrook R; Wilkoff BL
JACC Clin Electrophysiol; 2022 Jan; 8(1):101-111. PubMed ID: 34600848
[TBL] [Abstract][Full Text] [Related]
12. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.
Mittal S; Shaw RE; Michel K; Palekar R; Arshad A; Musat D; Preminger M; Sichrovsky T; Steinberg JS
Heart Rhythm; 2014 Apr; 11(4):595-601. PubMed ID: 24333543
[TBL] [Abstract][Full Text] [Related]
13. Postoperative antibiotic prophylaxis in the prevention of cardiac implantable electronic device infection.
Madadi S; Kafi M; Kheirkhah J; Azhari A; Kiarsi M; Mehryar A; Fazelifar A; Alizadehdiz A; Emkanjoo Z; Haghjoo M
Pacing Clin Electrophysiol; 2019 Feb; 42(2):161-165. PubMed ID: 30575054
[TBL] [Abstract][Full Text] [Related]
14. Retrospective comparative analysis of cardiovascular implantable electronic device infections with and without the use of antibacterial envelopes.
Hassoun A; Thottacherry ED; Raja M; Scully M; Azarbal A
J Hosp Infect; 2017 Mar; 95(3):286-291. PubMed ID: 28131641
[TBL] [Abstract][Full Text] [Related]
15. Proposal for a Novel Score to Determine the Risk of Cardiac Implantable Electronic Device Infection.
Calderón-Parra J; Sánchez-Chica E; Asensio-Vegas Á; Fernández-Lozano I; Toquero-Ramos J; Castro-Urda V; Royuela-Vicente A; Ramos-Martínez A
Rev Esp Cardiol (Engl Ed); 2019 Oct; 72(10):806-812. PubMed ID: 30340923
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Cardiac Implantable Electronic Device Infections: Single Operator Technique with Use of Povidone-Iodine, Double Gloving, Meticulous Aseptic/Antiseptic Measures and Antibiotic Prophylaxis.
Manolis AS; Melita H
Pacing Clin Electrophysiol; 2017 Jan; 40(1):26-34. PubMed ID: 27996097
[TBL] [Abstract][Full Text] [Related]
17. Economic impact of introducing TYRX amongst patients with heart failure and reduced ejection fraction undergoing implanted cardiac device procedures: a retrospective model based cost analysis.
Burnhope E; Rodriguez-Guadarrama Y; Waring M; Guilder A; Malhotra B; Razavi R; Rinaldi CA; Pennington M; Carr-White G
J Med Econ; 2019 May; 22(5):464-470. PubMed ID: 30744444
[TBL] [Abstract][Full Text] [Related]
18. REducing INFectiOns thRough Cardiac device Envelope: insight from real world data. The REINFORCE project.
Ziacchi M; Biffi M; Iacopino S; di Silvestro M; Marchese P; Miscio F; Caccavo VP; Zanotto G; Tomasi L; Dello Russo A; Donazzan L; Boriani G
Europace; 2023 Nov; 25(11):. PubMed ID: 37490930
[TBL] [Abstract][Full Text] [Related]
19. Low-temperature electrocautery reduces adverse effects from secondary cardiac implantable electronic device procedures: Insights from the WRAP-IT trial.
Mittal S; Wilkoff BL; Poole JE; Kennergren C; Wright DJ; Berman BJ; Riggio D; Sholevar DP; Martinez-Arraras J; Moubarak JB; Schaller RD; Love JC; Pickett RA; Philippon F; Eldadah Z; Lande JD; Lexcen DR; Holbrook R; Tarakji KG
Heart Rhythm; 2021 Jul; 18(7):1142-1150. PubMed ID: 33781980
[TBL] [Abstract][Full Text] [Related]
20. Reduced incidence of CIED infections with peri- and post-operative antibiotic use in CRT-P/D and ICD procedures.
Senaratne JM; Wijesundera J; Chhetri U; Beaudette D; Sander A; Hanninen M; Gulamhusein S; Senaratne M
Medicine (Baltimore); 2022 Oct; 101(40):e30944. PubMed ID: 36221436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
